Karel Petrak
Radiopharmaceuticals utilized in standard atomic medication for patients with bosom malignancy are a notable wellspring of ionizing radiation, emitating gamma-photon particles: tumorotroponin cationic edifices like 99mTc-Sestamibi/Tetrofosmin (MIBI/TF); radiolabelled somatostatin analogs 111In-Ocrteoscan/99mTc-Tektrotyd; 99mTc-MDP; 99mTc-Nanocoll and so on The serious tracer take-up of the various radiopharmaceuticals relies upon the blood perfusion and their bio distribution, the proliferative movement of the tumor cells, the oxygen utilization, receptor status, and different elements of various tumors. For instance the tumorotroponin cation complex 99mTc-MIBI packs in the mitochondria while 99mTc-TF take-up is likewise in the cytosol, because of the reality, that in dynamic proliferative cells they are found in greater amount.
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi